Profile data is unavailable for this security.
About the company
Humanwell Healthcare Group Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company primarily operates its businesses through two segments. Pharmaceutical segment is mainly engaged in the research and development, production and sales of pharmaceutical products and the research and development, production and sales of medical device products, as well as the delivery, distribution and related businesses of pharmaceutical products, providing drugs, devices, medical equipment, reagents, consumables, health products, as well as technology and management services. The Company's products include chemical pharmaceutical preparations, chemical active pharmaceutical ingredients and others. Environmental Protection segment is primarily engaged in environmental protection engineering business.
- Revenue in CNY (TTM)24.18bn
- Net income in CNY1.43bn
- Incorporated1993
- Employees17.65k
- LocationHumanwell Healthcare Group Co LtdNo. 666 Gaoxin AvenueDonghu High-Tech DistrictWUHAN 430075ChinaCHN
- Phone+86 2 787597232
- Fax+86 2 787596393
- Websitehttp://www.humanwell.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kangmei Pharmaceutical Co Ltd | 5.28bn | 16.64m | 26.55bn | 4.23k | 1,669.57 | 3.69 | -- | 5.03 | 0.0012 | 0.0012 | 0.3973 | 0.5197 | 0.3785 | 1.64 | 2.23 | 1,246,204.00 | 0.1368 | -21.82 | 0.2232 | -42.17 | 17.12 | -92.73 | 0.3614 | -108.18 | 0.7875 | -- | 0.0162 | -- | 6.47 | -14.63 | -91.64 | -- | -33.46 | -- |
| Xiamen Amoytop Biotech Co Ltd | 3.34bn | 939.58m | 28.09bn | 2.42k | 29.80 | 9.30 | -- | 8.41 | 2.31 | 2.31 | 8.22 | 7.40 | 1.03 | 0.8127 | 4.99 | 1,379,284.00 | 29.05 | 22.72 | 33.93 | 26.54 | 92.37 | 91.62 | 28.11 | 23.51 | 3.20 | -- | 0.0448 | 28.80 | 34.13 | 31.02 | 49.00 | 66.70 | 41.17 | 90.06 |
| Bluestar Adisseo Co | 17.09bn | 1.19bn | 30.24bn | 2.93k | 22.08 | 1.56 | -- | 1.77 | 0.4447 | 0.4447 | 6.37 | 6.31 | 0.7204 | 5.30 | 8.18 | 5,834,541.00 | 5.03 | 5.20 | 6.05 | 6.63 | 27.69 | 29.69 | 6.99 | 8.12 | 1.12 | 10.31 | 0.1377 | 30.01 | 17.83 | 6.88 | 2,208.66 | 3.95 | 5.53 | -7.02 |
| Humanwell Healthcare Group Co Ltd | 24.18bn | 1.43bn | 31.31bn | 17.65k | 21.94 | 1.66 | -- | 1.29 | 0.8741 | 0.8741 | 14.84 | 11.59 | 0.6519 | 3.63 | 2.48 | 1,369,715.00 | 5.00 | 6.40 | 8.73 | 12.55 | 44.53 | 43.83 | 7.67 | 9.90 | 1.40 | 362.14 | 0.2889 | 25.97 | 3.71 | 3.13 | -37.70 | 11.15 | 4.75 | 56.54 |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 5.37bn | 3.58bn | 31.45bn | 3.84k | 10.09 | 4.01 | -- | 5.86 | 4.65 | 4.65 | 6.98 | 11.70 | 0.4758 | 1.35 | 3.16 | 1,399,130.00 | 31.64 | 11.74 | 45.06 | 16.76 | 64.27 | 42.04 | 66.50 | 14.81 | 2.33 | -- | 0.0056 | 54.04 | -11.14 | 0.8791 | 125.94 | 28.94 | -10.54 | 33.67 |
| Shanghai Junshi Biosciences Co Ltd | 2.48bn | -949.86m | 32.17bn | 2.67k | -- | 5.85 | -- | 12.95 | -0.96 | -0.96 | 2.51 | 6.05 | 0.2203 | 0.8436 | 5.48 | 963,148.80 | -9.45 | -17.61 | -12.31 | -22.00 | 81.59 | 68.46 | -42.92 | -84.56 | 1.43 | -23.04 | 0.3629 | -- | 29.67 | 20.24 | 43.90 | -- | -4.33 | -- |
| Beijing Tiantan Biological Products Corp | 6.42bn | 1.32bn | 32.77bn | 5.30k | 24.89 | 2.86 | -- | 5.10 | 0.6656 | 0.6656 | 3.25 | 5.80 | 0.4002 | 0.9382 | 11.21 | 1,212,453.00 | 11.25 | 11.93 | 16.06 | 16.79 | 45.65 | 50.69 | 28.10 | 29.69 | 3.08 | -- | 0.0152 | 16.24 | 16.44 | 12.94 | 39.58 | 20.45 | 15.19 | 23.56 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.37bn | 870.39m | 36.90bn | 995.00 | 42.59 | 6.24 | -- | 26.93 | 1.40 | 1.40 | 2.21 | 9.56 | 0.186 | 1.54 | 4.55 | 1,377,045.00 | 11.66 | 3.14 | 15.35 | 3.34 | 74.88 | 77.37 | 62.65 | 16.95 | 1.97 | -- | 0.00 | 12.57 | 17.70 | 0.2733 | 139.15 | 25.17 | 16.61 | -- |
Data as of Feb 10 2026. Currency figures normalised to Humanwell Healthcare Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
28.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| COFCO Trust Co., Ltd.as of 22 Dec 2025 | 190.90m | 13.10% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 53.61m | 3.68% |
| China Life Asset Management Co., Ltd.as of 30 Sep 2024 | 39.26m | 2.69% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 32.61m | 2.24% |
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2024 | 27.21m | 1.87% |
| China Southern Asset Management Co., Ltd.as of 30 Sep 2024 | 20.45m | 1.40% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 17.11m | 1.17% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 16.21m | 1.11% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 13.04m | 0.90% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 11.26m | 0.77% |
More ▼
Data from 30 Jun 2025 - 22 Dec 2025Source: FactSet Research Systems Inc.
